Who Paid My Doc Search
Menu
Research study Program year 2025 Source: CMS Open Payments

M23-721 - Study to Evaluate Adverse Events Optimal Dose and Change in Disease Activity With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Research payments

$114,216

20 payments

Through program year 2025, $114,216 in research payments was reported against M23-721 - Study to Evaluate Adverse Events Optimal Dose and Change in Disease Activity With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC), across 20 payments, paid by AbbVie, Inc..

Paid by
AbbVie, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2025 Research $114,216 20

Breakdown

Who paid Research payments · program year 2025
  1. AbbVie, Inc. $114,216 20 payments
Who received the money Research payments · program year 2025
  1. Texas Oncology PA Organisation paid for research $27,525 4 payments
  2. Cancer And Hematology Centers Of Organisation paid for research $25,006 8 payments
  3. University Of Kansas Medical Center Organisation paid for research $24,716 3 payments
  4. The Moses H. Cone Memorial Hospital Teaching hospital · NC $18,000 1 payment
  5. Washington University Organisation paid for research $14,885 2 payments
  6. American Oncology Partners PA Organisation paid for research $3,085 1 payment
  7. Donald Guthrie Fndn For Education Organisation paid for research $1,000 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record